PMID- 26276818 OWN - NLM STAT- MEDLINE DCOM- 20151229 LR - 20200930 IS - 1522-1539 (Electronic) IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 309 IP - 7 DP - 2015 Oct TI - Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction. PG - H1198-206 LID - 10.1152/ajpheart.00393.2015 [doi] AB - This paper aims to determine whether chronic vagus nerve stimulation (VNS) mitigates myocardial infarction (MI)-induced remodeling of the intrinsic cardiac nervous system (ICNS), along with the cardiac tissue it regulates. Guinea pigs underwent VNS implantation on the right cervical vagus. Two weeks later, MI was produced by ligating the ventral descending coronary artery. VNS stimulation started 7 days post-MI (20 Hz, 0.9 +/- 0.2 mA, 14 s on, 48 s off; VNS-MI, n = 7) and was compared with time-matched MI animals with sham VNS (MI n = 7) vs. untreated controls (n = 8). Echocardiograms were performed before and at 90 days post-MI. At termination, IC neuronal intracellular voltage recordings were obtained from whole-mount neuronal plexuses. MI increased left ventricular end systolic volume (LVESV) 30% (P = 0.027) and reduced LV ejection fraction (LVEF) 6.5% (P < 0.001) at 90 days post-MI compared with baseline. In the VNS-MI group, LVESV and LVEF did not differ from baseline. IC neurons showed depolarization of resting membrane potentials and increased input resistance in MI compared with VNS-MI and sham controls (P < 0.05). Neuronal excitability and sensitivity to norepinephrine increased in MI and VNS-MI groups compared with controls (P < 0.05). Synaptic efficacy, as determined by evoked responses to stimulating input axons, was reduced in VNS-MI compared with MI or controls (P < 0.05). VNS induced changes in myocytes, consistent with enhanced glycogenolysis, and blunted the MI-induced increase in the proapoptotic Bcl-2-associated X protein (P < 0.05). VNS mitigates MI-induced remodeling of the ICNS, correspondingly preserving ventricular function via both neural and cardiomyocyte-dependent actions. CI - Copyright (c) 2015 the American Physiological Society. FAU - Beaumont, Eric AU - Beaumont E AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; FAU - Southerland, Elizabeth M AU - Southerland EM AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; FAU - Hardwick, Jean C AU - Hardwick JC AD - Department of Biology, Ithaca College, Ithaca, New York; FAU - Wright, Gary L AU - Wright GL AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; FAU - Ryan, Shannon AU - Ryan S AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; FAU - Li, Ying AU - Li Y AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; FAU - KenKnight, Bruce H AU - KenKnight BH AD - Cyberonics, Houston, Texas; and. FAU - Armour, J Andrew AU - Armour JA AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; Department of Medicine, University of California Los Angeles Health System, Los Angeles, California. FAU - Ardell, Jeffrey L AU - Ardell JL AD - Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee; Department of Medicine, University of California Los Angeles Health System, Los Angeles, California jardell@mednet.ucla.edu. LA - eng GR - HL09889/HL/NHLBI NIH HHS/United States GR - HL71830/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150814 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (bcl-2-Associated X Protein) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - Animals MH - Autonomic Nervous System/*physiopathology MH - Evoked Potentials MH - Glycogenolysis MH - Guinea Pigs MH - Heart/*innervation MH - Membrane Potentials MH - Myocardial Infarction/*physiopathology MH - Myocytes, Cardiac/*metabolism MH - Neuronal Plasticity/*physiology MH - Norepinephrine/metabolism MH - Stroke Volume/physiology MH - Synaptic Transmission MH - *Vagus Nerve Stimulation MH - Ventricular Dysfunction, Left/*physiopathology MH - Ventricular Function, Left MH - bcl-2-Associated X Protein/metabolism PMC - PMC4666924 OTO - NOTNLM OT - autonomic regulation therapy OT - guinea pig OT - intrinsic cardiac nervous system OT - myocardial infarction OT - vagus nerve stimulation EDAT- 2015/08/16 06:00 MHDA- 2015/12/30 06:00 PMCR- 2016/10/01 CRDT- 2015/08/16 06:00 PHST- 2015/05/27 00:00 [received] PHST- 2015/08/10 00:00 [accepted] PHST- 2015/08/16 06:00 [entrez] PHST- 2015/08/16 06:00 [pubmed] PHST- 2015/12/30 06:00 [medline] PHST- 2016/10/01 00:00 [pmc-release] AID - ajpheart.00393.2015 [pii] AID - H-00393-2015 [pii] AID - 10.1152/ajpheart.00393.2015 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1198-206. doi: 10.1152/ajpheart.00393.2015. Epub 2015 Aug 14.